We hereby announce that there has been a change in the Representative Director as of March 1, 2025.
Details
| Name | New Position | Current Position |
| Katsuhiro Uto | Representative Director & CEO (also Director of RaQualia Pharma Inc.) |
Director (also Director of RaQualia Pharma Inc.) |
| Yusuke Tominari | Director | Representative Director & CEO |
Reason for Change
The RaQualia Group prioritizes achieving the business plan announced on February 14, 2025, aiming to enhance growth potential, corporate value, and shareholder value. This change is intended to further strengthen collaboration within the group, optimize management resources, enhance business competitiveness, and accelerate goal achievement.
###
FIMECS, Inc. Media and Investor Contact:
FIMECS, Inc.
26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-0012, Japan
Tel: +81-466-96-0261
Email: info@fimecs.com